Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer

This study demonstrated strong individual- and trial-level surrogacy between RFS and OS in resectable esophageal cancer across all perioperative treatments. These findings may accelerate perioperative treatment development by shortening follow-up in esophageal cancer trials.

Authors

Institutions

Publication Details

Journal
Annals of Surgery
Published
2025-08-25
DOI
https://doi.org/10.1097/sla.0000000000006919
Citations
2
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer

Thomas Ruhstaller, Yuko Kitagawa, Yasunori Sato, Guillaume Piessen et al.
2 citations
Annals of Surgery
Esophageal Cancer Research and Treatment
4.01
article

Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer

Thomas Ruhstaller, Yuko Kitagawa, Yasunori Sato, Guillaume Piessen, Bianca Mostert, Kengo Nagashima, Charlène J. van der Zijden, Bas P. L. Wijnhoven, Hiroya Takeuchi, Shaoyuan Zhang, Thomas Aparicio, Jun Okui, Fredrik Klevebro, Satoru Matsuda, Peter Thuss‐Patience, Lijie Tan, Hirofumi Kawakubo, Takahiro Tsushima, Magnus Nilsson, Ken Kato
article en
2 citations

Abstract

This study demonstrated strong individual- and trial-level surrogacy between RFS and OS in resectable esophageal cancer across all perioperative treatments. These findings may accelerate perioperative treatment development by shortening follow-up in esophageal cancer trials.

Annals of Surgery
Centre National de la Recherche Scientifique (FR), Karolinska University Hospital (SE), Inserm (FR), Sun Yat-sen University (CN), University of Basel (CH), Keio University (JP), Université Paris Cité (FR), Université de Lille (FR), Fudan University (CN), Erasmus MC (NL), Karolinska Institutet (SE), Centre Hospitalier Universitaire de Lille (FR), Hamamatsu University School of Medicine (JP), Shizuoka Cancer Center (JP), Assistance Publique – Hôpitaux de Paris (FR), Keio University Hospital (JP), Zhongshan Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Hôpital Saint-Louis (FR), National Cancer Center Hospital East (JP), Swiss Group For Clinical Cancer Research (CH), Erasmus MC Cancer Institute (NL), CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers (FR), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 6%
Esophageal Cancer Research and Treatment
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.